ResearcherTokai UniversityActive in the last 2 years

Masaki Mori

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5130981843. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 3

Papers, trials and grants by year

2026: 2 papers

Papers 2

Therapeutic Potential of miR-4711-5p in Pancreatic Cancer: Antitumor Activity and Mechanistic Insights. Last author DOI 10.3390/cancers18071104 ↗
miR-136-5p Preferentially Suppresses Cancer Stem-like Cells in Pancreatic Cancer. Last author DOI 10.3390/ijms27083686 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Hiroyuki Yamamoto · 2 shared papers, 2026 · strength 0.49
- Paper miR-136-5p Preferentially Suppresses Cancer Stem-like Cells in Pancreatic Cancer. DOI 10.3390/ijms27083686 ↗
- Paper Therapeutic Potential of miR-4711-5p in Pancreatic Cancer: Antitumor Activity and Mechanistic Insights. DOI 10.3390/cancers18071104 ↗
Yuhki Yokoyama · 2 shared papers, 2026 · strength 0.49
- Paper miR-136-5p Preferentially Suppresses Cancer Stem-like Cells in Pancreatic Cancer. DOI 10.3390/ijms27083686 ↗
- Paper Therapeutic Potential of miR-4711-5p in Pancreatic Cancer: Antitumor Activity and Mechanistic Insights. DOI 10.3390/cancers18071104 ↗
Hirofumi Yamamoto · 1 shared paper, 2026 · strength 0.25
- Paper miR-136-5p Preferentially Suppresses Cancer Stem-like Cells in Pancreatic Cancer. DOI 10.3390/ijms27083686 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.